Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 1751 - 1760 of 2501

  • Penn Medicine receives $22 million from NIH HEAL initiative to address the national opioid crisis

    The National Institutes of Health (NIH) announced awards from the Helping to End Addiction Long-term Initiative (NIH HEAL Initiative), which was launched in April 2018 to improve prevention and treatment strategies for opioid misuse and addiction and enhance pain management. Though this initiative, Penn Medicine has been awarded five grants totaling more than $22 million to apply scientific solutions to reverse the national opioid crisis.

    FULL STORY AT Penn Medicine News →

  • Penn researchers receive $18 million grant to study connection between Alzheimer’s, dementia, and Parkinson’s disease

    The Center for Neurodegenerative Disease Research has received a grant to study the underlying genetic mechanisms that cause Alzheimer’s Disease, Dementia, and Parkinson’s Disease to progress, as well as how those mechanisms are related to each other and to the cell-to-cell spread of these disease proteins.

    FULL STORY AT Penn Medicine News →

  • Duckworth and Hamilton are Distinguished Daughters of Pennsylvania

    Angela Duckworth, Christopher H. Browne Distinguished Professor of Psychology, and Marci Hamilton, Robert A. Fox Leadership Program Professor of Practice, were recently selected as 2019 Daughters of Pennsylvania, which recognizes outstanding women for their extraordinary service and contributions to Pennsylvania. 

    FULL STORY AT Penn Arts & Sciences →

  • Prediction system significantly increases palliative care consults

    Palliative Connect, a trigger system developed at Penn Medicine and powered by predictive analytics, was found to be effective at increasing palliative care consultations for seriously ill patients.

    FULL STORY AT Penn Medicine News →

  • Oncologists respond swiftly to FDA safety alerts

    Within six months of the U.S. Food and Drug Administration’s (FDA) move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent.

    FULL STORY AT Penn Medicine News →

  • Track & Field releases 2019-20 schedule

    Director of Track & Field/Cross Country Steve Dolan announced on Monday a challenging 2019-20 schedule, featuring top competition around the country. The goal, he says, is “to set up a schedule that allows both our men’s and women's teams to excel at the highest level across all event areas.”

    FULL STORY AT Penn Athletics →

  • How to successfully recruit minority adolescents for STI/HIV prevention research

    A new paper published in the Journal of Racial and Ethnic Health Disparities outlines successful practices in facilitating recruitment, achieving study aims for adolescent engagement, and ensuring more efficient use of human and material resources in racial/ ethnic minority adolescent STI/HIV prevention research.

    FULL STORY AT Penn Nursing News →

  • The GM strike: What are the mounting costs?

    Wharton’s John Paul MacDuffie discusses fallout from the GM strike and the threat of a wider impact across the U.S. economy.

    FULL STORY AT Knowledge at Wharton →

  • Radiation may lower potential for side effects of CAR T therapy in non-Hodgkin’s lymphoma

    A Penn study shows the benefit of radiation given 30 days or less before CAR T infusion, where patients did not experience serious cytokine release syndrome or neurotoxicity.

    FULL STORY AT Penn Medicine News →

  • American Academy of Nursing announces new fellows

    Eight nursing professionals with ties to Penn Nursing will be inducted as 2019 Fellows of the American Academy of Nursing. Two are current Penn employees and alumnae; one being a current faculty member; and the other being a program director at Penn Medicine’s Abramson Cancer Center. The additional six are Penn Nursing alumni.

    FULL STORY AT Penn Nursing News →